DNA
ActiveSummary
The computed 12-month bankruptcy probability of DNA is 2.3% (moderate). The 2025 annual accounts show negative equity (-€357,893) and a net result of -€164,528. Equity is shrinking by about 54% per year across the filed financial years. Its solvency ranks better than 15% of 1,364 sector peers (NACE 96, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
14-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Weakest financial yearnet -€164,528
Net result drops to -€164,528, the lowest in the series.
15-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
18-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
31-12
Financial
Back to profitnet €4,826
Net result €4,826 after 3 loss-making years.
18-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
23-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
23-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.